enVVeno Medical
NVNO
36 hedge funds and large institutions have $17.5M invested in enVVeno Medical in 2024 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 0 closing their positions.
964% more call options, than puts
Call options by funds: $383K | Put options by funds: $36K
57% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 7
38% more funds holding
Funds holding: 26 → 36 (+10)
1% more capital invested
Capital invested by funds: $17.3M → $17.5M (+$234K)
0.41% more ownership
Funds ownership: 0.71% → 1.12% (+0.41%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
+$2.23M |
| 2 |
ACM
Altium Capital Management
New York
|
+$1.25M |
| 3 |
KCM
Kingdon Capital Management
New York
|
+$1.08M |
| 4 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$769K |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$625K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LNWTC
Laird Norton Wetherby Trust Company
Seattle,
Washington
|
-$42.1K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$32.1K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$8.08K |
| 4 |
FA
Fermata Advisors
Sonoma,
California
|
-$3.67K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$2.94K |
NVNO Hedge Fund Activity: Q3 2024 in Review
36 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in enVVeno Medical (NVNO) for Q3 2024, worth a combined $17.5M — up 1.4% from $17.3M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new NVNO positions and 0 closed out — a net gain of 10 holders — while 11 added to existing stakes and 7 trimmed.
The largest buyer was Alyeska Investment Group, opening a new position worth an estimated $2.23M. The largest seller was Laird Norton Wetherby Trust Company, cutting an estimated $42.1K.
- 36 institutional investors held enVVeno Medical (NVNO) as of Q3 2024, up from 26 in Q2 2024.
- Funds reported $17.5M of enVVeno Medical stock for Q3 2024, up 1.4% quarter-over-quarter.
- 10 funds opened new enVVeno Medical positions in Q3 2024 and 0 closed out, a net change of +10 holders.
- The largest enVVeno Medical buyer in Q3 2024 was Alyeska Investment Group, an estimated $2.23M added.
- The largest enVVeno Medical seller in Q3 2024 was Laird Norton Wetherby Trust Company, an estimated $42.1K sold.
Based on aggregated 13F filings for Q3 2024.